FDA chemist pleads guilty to scam involving pharmaceutical stocks
A Food and Drug Administration chemist pleaded guilty on Tuesday to using confidential government information about pending FDA drug approvals to make millions in profits by trading pharmaceutical company stocks.

FDA official urges smart regulation
Caught between wary patients who want safe artificial hips and demanding medical-device manufacturers who want their potentially lucrative gizmos approved yesterday, the top device official at the U.S. Food and Drug Administration told skeptical industry executives gathered Monday at the Convention Center that he was trying to institute a paradigm shift to help all parties.